Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
European Journal of Medical Research
|
May 28, 2008
Switch to efavirenz (EFV) after protease-inhibitor (PI)-failure: explorative analysis of outcome by baseline viral VS tolerability failure
Pavel Khaykin, N Postel, I Reeb, et al.
European Journal of Medical Research
|
August 26, 2000
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study
V Rickerts, H Brodt, S Staszewski, et al.
AIDS (London, England)
|
November 14, 1998
HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors
S Staszewski, R DeMasi, A M Hill, et al.
MMW, Munchener Medizinische Wochenschrift
|
March 18, 1983
[Toxic shock syndrome. Description of 2 cases from the Frankfurt district]
S Staszewski, M Neubauer, E B Helm, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 20, 1987
[HIV-2 infection also in Germany]
S Staszewski, W Stille, A Werner, et al.
AIDS (London, England)
|
January 1, 1997
Clinical experience with non-nucleoside reverse transcriptase inhibitors
V Miller, S Staszewski, C A Boucher, et al.
HIV Medicine
|
December 12, 2001
A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient
V Rickerts, M Bickel, J Tews, et al.
Journal of Medical Virology
|
September 1, 1994
Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems
C M Nübling, G von Wangenheim, S Staszewski, et al.
Experimental Hematology
|
May 1, 1989
Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS
A Ganser, J Greher, B Völkers, et al.
Lancet (London, England)
|
February 18, 1989
Overdosage of zidovudine
S Staszewski, S Rehmet, J Odewald, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
European Journal of Medical Research
|
May 28, 2008
Switch to efavirenz (EFV) after protease-inhibitor (PI)-failure: explorative analysis of outcome by baseline viral VS tolerability failure
Pavel Khaykin, N Postel, I Reeb, et al.
European Journal of Medical Research
|
August 26, 2000
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study
V Rickerts, H Brodt, S Staszewski, et al.
AIDS (London, England)
|
November 14, 1998
HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors
S Staszewski, R DeMasi, A M Hill, et al.
MMW, Munchener Medizinische Wochenschrift
|
March 18, 1983
[Toxic shock syndrome. Description of 2 cases from the Frankfurt district]
S Staszewski, M Neubauer, E B Helm, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 20, 1987
[HIV-2 infection also in Germany]
S Staszewski, W Stille, A Werner, et al.
AIDS (London, England)
|
January 1, 1997
Clinical experience with non-nucleoside reverse transcriptase inhibitors
V Miller, S Staszewski, C A Boucher, et al.
HIV Medicine
|
December 12, 2001
A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient
V Rickerts, M Bickel, J Tews, et al.
Journal of Medical Virology
|
September 1, 1994
Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems
C M Nübling, G von Wangenheim, S Staszewski, et al.
Experimental Hematology
|
May 1, 1989
Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS
A Ganser, J Greher, B Völkers, et al.
Lancet (London, England)
|
February 18, 1989
Overdosage of zidovudine
S Staszewski, S Rehmet, J Odewald, et al.
Page
of 10